Following a granting process in late 2016, an investment of $4.8 million was awarded to Round 1 projects in April 2017. 

In Round 1, Queensland Genomics program design was based on:

  • The conduct of a number of clinical projects in specific disease areas;
  • The concurrent establishment of five capability-building projects to build capability in key areas of the health system.

Round 1 clinical and capability-building projects ran from September 2017 until March 2019.

Clinical demonstration projects

The objective of the Round 1 clinical projects was to evaluate the use of genomic sequencing to diagnose and manage patients in specific disease areas.

Four disease areas were selected as clinical projects in Round 1:

Capability building

A core theme of Queensland Genomics’ objectives is to build capability and infrastructure to implement clinical genomics in Queensland healthcare.